COVID-19 in MS

James D. Bowen, Justine Brink, Ted R. Brown, Elisabeth B. Lucassen, Kyle Smoot, Annette Wundes, Pavle Repovic

Neurology Neuroimmunology & Neuroinflammation · 2020 · 36 citations · 3 references

DOIFull text

Open access

Concepts

Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is marked by a wide range and severity of symptoms. Most patients have mild to moderate symptoms, whereas 10%–15% require hospitalization. Mortality is higher with cardiovascular disorders, diabetes, and older age.1

References

3